Atara Biotherapeutics Inc (ATRA) stock has gained 9.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ATRA stock a score of 65 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 76. In addition to the average rating from Wall Street analysts, ATRA stock has a mean target price of $27.80. This means analysts expect the stock to gain 83.50% over the next 12 months. ATRA's rank also includes a long-term technical score of 66. The short-term technical score for ATRA is 55.
ATRA has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ATRA!
Atara Biotherapeutics Inc (ATRA) stock is down -3.28% while the S&P 500 has gained 1.38% as of 11:06 AM on Thursday, Oct 14. ATRA has fallen -$0.51 from the previous closing price of $15.66 on volume of 384,907 shares. Over the past year the S&P 500 is higher by 26.81% while ATRA has gained 9.23%. ATRA lost -$3.63 per share in the over the last 12 months.
Click Here to get the full Stock Report for Atara Biotherapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
